PHENYLALANINE: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews

Overview

Phenylalanine is an amino acid. There are three forms: L-, D-, and DL- phenylalanine. L-phenylalanine is found naturally in foods such as meat and eggs.

Amino acids are the building blocks of protein. L-phenylalanine is an essential amino acid. It is the only form of phenylalanine found in proteins. D-phenylalanine is not an essential amino acid, and its role in the body is not currently understood. DL-phenylalanine is made in a lab.

People use phenylalanine for a disorder that causes white patches to develop on the skin (vitiligo). It is also used for attention-deficit hyperactivity disorder (ADHD), chronic pain, aging skin, depression, and many other purposes, but there is no good scientific evidence to support most of these uses.

Uses & Effectiveness

Possibly Effective for

A skin disorder that causes white patches to develop on the skin (vitiligo). Taking L-phenylalanine by mouth, or applying it to the skin, both in combination with UVA light, seems to improve symptoms of vitiligo.

Possibly Ineffective for

Attention deficit-hyperactivity disorder (ADHD). Taking phenylalanine by mouth doesn't seem to help ADHD.
Chronic pain. Taking D-phenylalanine by mouth does not seem to reduce pain.

There is interest in using phenylalanine for a number of other purposes, but there isn't enough reliable information to say whether it might be helpful.

Side Effects

When taken by mouth: L-phenylalanine is commonly consumed in foods. L-phenylalanine, D-phenylalanine, and DL-phenylalanine are possibly safe when used as medicine, short-term. Side effects might include anxiety, headache, and constipation.

When applied to the skin: Phenylalanine cream is possibly safe when used short-term.

Special Precautions and Warnings

Pregnancy: L-phenylalanine is commonly consumed in foods. But having too much phenylalanine during pregnancy can increase the chance of birth defects. For patients who process phenylalanine normally and have normal levels, it is fine to consume phenylalanine in typical food amounts, but supplements containing phenylalanine should be avoided. For pregnant patients who have high levels of phenylalanine, such as those with a condition called phenylketonuria (PKU), even normal food amounts are unsafe. For these patients, experts recommend a low phenylalanine diet for at least 20 weeks before getting pregnant. This should reduce the risk of birth defects.

Breast-feeding: L-phenylalanine is commonly consumed in foods. But there isn't enough reliable information to know if any form of phenylalanine is safe to use in larger amounts as medicine while breast-feeding. Stay on the safe side and avoid use.

Phenylketonuria (PKU) and other conditions that cause high levels of phenylalanine: Some people have inherited disorders, such as PKU, that cause their bodies to build up too much phenylalanine. This can cause developmental delay, high blood pressure, stroke, and many other serious health issues. If you have one of these disorders, avoid phenylalanine supplements.

Schizophrenia: Some people with schizophrenia have a movement disorder called tardive dyskinesia. Phenylalanine might make this movement disorder worse.

Interactions

Major Interaction

Do not take this combination

Levodopa interacts with PHENYLALANINE
Levodopa is used for Parkinson disease. Taking phenylalanine along with levodopa can make Parkinson disease worse. Do not take phenylalanine if you are taking levodopa.

Moderate Interaction

Be cautious with this combination

Medications for depression (MAOIs) interacts with PHENYLALANINE
Phenylalanine can increase a chemical in the body called tyramine. Large amounts of tyramine can cause high blood pressure. Some medications used for depression stop the body from breaking down tyramine. This can cause there to be too much tyramine and lead to dangerously high blood pressure.

Some common MAOIs include phenelzine (Nardil), selegiline (Zelapar), and tranylcypromine (Parnate).
Baclofen interacts with PHENYLALANINE
Phenylalanine might decrease how much baclofen the body absorbs. This might decrease the effects of baclofen.

Dosing

L-phenylalanine is an essential amino acid found in foods including meat, fish, eggs, cheese, and milk.

As medicine, L-phenylalanine, D-phenylalanine, and DL-phenylalanine have been used in varying doses. L-phenylalanine has most often been used by adults in doses of 250 mg or 100 mg/kg by mouth daily for up to 3 months. Speak with a healthcare provider to find out what form and dose might be best for a specific condition.

View References

REFERENCES:

Kinnunen O, Winblad I, Koistinen P, Salokannel J. Safety and efficacy of a bulk laxative containing senna versus lactulose in the treatment of chronic constipation in geriatric patients. Pharmacology 1993;47:253-5. View abstract.

Kittisupamongkol W, Nilaratanakul V, Kulwichit W. Near-fatal bleeding, senna, and the opposite of lettuce. Lancet 2008;371:784. View abstract.

Langmead L, Rampton DS. Review article: herbal treatment in gastrointestinal and liver disease--benefits and dangers. Aliment Pharmacol Ther 2001;15:1239-52. View abstract.

MacLennan WJ, Pooler AFWM. A comparison of sodium picosulphate ("Laxoberal") with standardised senna ("Senokot") in geriatric patients. Curr Med Res Opin. 1974;2:641-7. View abstract.

Marlett JA, Li BU, Patrow CJ, Bass P. Comparative laxation of psyllium with and without senna in an ambulatory constipated population. Am J Gastroenterol 1987;82:333-7. View abstract.

Morishita D, Tomita T, Mori S, et al. Senna Versus Magnesium Oxide for the Treatment of Chronic Constipation: A Randomized, Placebo-Controlled Trial. Am J Gastroenterol 2021;116(1):152-161. View abstract.

National Toxicology Program. Toxicology study of senna (CAS No. 8013-11-4) in C57BL/6NTAC mice and toxicology and carcinogenesis study of senna in genetically modified C3B6.129F1/Tac-Trp53tm1Brd haploinsufficient mice (feed studies). Natl Toxicol Program Genet Modif Model Rep 2012;(15):1-114.View abstract.

Nusko G, Schneider B, Schneider I, et al. Anthranoid laxative use is not a risk factor for colorectal neoplasia: results of a prospective case control study. Gut 2000;46:651-5. View abstract.

Passmore AP, Davies KW, Flanagan PG, et al. A comparison of Agiolax and lactulose in elderly patients with chronic constipation. Pharmacology 1993;47:249-52. View abstract.

Passmore AP, Wilson-Davies K, Stoker C, Scott ME. Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fibre combination. BMJ 1993;307:769-71. View abstract.

Perkin JM. Constipation in childhood: a controlled comparison between lactulose and standardized senna. Curr Med Res Opin 1977;4:540-3. View abstract.

Poyrazoglu OK, Yalniz M. Two low-dose bowel-cleansing regimens: efficacy and safety of senna and sodium phosphorus solution for colonoscopy. Patient Prefer Adherence 2015;9:1325-31.View abstract.

Prather CM. Pregnancy-related constipation. Curr Gastroenterol Rep 2004;6:402-4. View abstract.

Prior J, White I. Tetany and clubbing in patient who ingested large quantities of senna. Lancet 1978;2:947. View abstract.

Ramesh PR, Kumar KS, Rajagopal MR, et al. Managing morphine-induced constipation: a controlled comparison of an Ayurvedic formulation and senna. J Pain Symptom Manage 1998;16:240-4. View abstract.

Senokot Package Labeling, Purdue Products, L.P. 2016

Senokot Package Labeling. Purdue Products L.P. 2007.

Seybold U, Landauer N, Hillebrand S, Goebel FD. Senna-induced hepatitis in a poor metabolizer. Ann Intern Med 2004;141:650-1. View abstract.

Shelton MG. Standardized senna in the management of constipation in the puerperium: A clinical trial. S Afr Med J 1980;57:78-80. View abstract.

Sondheimer JM, Gervaise EP. Lubricant versus laxative in the treatment of chronic functional constipation of children: a comparative study. J Pediatr Gastroenterol Nutr 1982;1:223-6. View abstract.

Tian H, Fan Y, Yang L, et al. The Efficacy of Senna Bowel Preparation for Colonoscopy: A Systematic Review and Meta-analysis. Gastroenterol Nurs 2022;45(6):428-439. View abstract.

van Os FH. Anthraquinone derivatives in vegetable laxatives. Pharmacology 1976;14:7-17. View abstract.

Vanderperren B, Rizzo M, Angenot L, et al. Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides. Ann Pharmacother 2005;39:1353-7. View abstract.

Vilanova-Sanchez A, Gasior AC, Toocheck N, et al. Are Senna based laxatives safe when used as long term treatment for constipation in children? J Pediatr Surg 2018;53(4):722-7. View abstract.

Werthmann WM Jr, Krees SV. Quantitative excretion of Senokot in human breast milk. Med Ann Dist Columbia 1973;42:4-5. View abstract.

Xing JH, Soffer EE. Adverse effects of laxatives. Dis Colon Rectum 2001;44:1201-9. View abstract.

Yenidogan E, Okan I, Kayaoglu HA, et al. Same-day colonoscopy preparation with Senna alkaloids and bisacodyl tablets: a pilot study. World J Gastroenterol 2014;20(41):15382-6.View abstract.

Beckmann, H. and Ludolph, E. [DL-phenylalanine as an antidepressant. Open study (author's transl)]. Arzneimittelforschung. 1978;28(8):1283-1284. View abstract.

Beckmann, H., Strauss, M. A., and Ludolph, E. Dl-phenylalanine in depressed patients: an open study. J.Neural Transm. 1977;41(2-3):123-134. View abstract.

Camacho, F. and Mazuecos, J. Oral and topical L-phenylalanine, clobetasol propionate, and UVA/sunlight--a new study for the treatment of vitiligo. J Drugs Dermatol 2002;1(2):127-131. View abstract.

Camacho, F. and Mazuecos, J. Treatment of vitiligo with oral and topical phenylalanine: 6 years of experience. Arch Dermatol 1999;135(2):216-217. View abstract.

Cotzias, G. C., Van Woert, M. H., and Schiffer, L. M. Aromatic amino acids and modification of parkinsonism. N Engl.J Med 2-16-1967;276(7):374-379. View abstract.

Fischer, E., Heller, B., Nachon, M., and Spatz, H. Therapy of depression by phenylalanine. Preliminary note. Arzneimittelforschung. 1975;25(1):132. View abstract.

Kravitz, H. M., Sabelli, H. C., and Fawcett, J. Dietary supplements of phenylalanine and other amino acid precursors of brain neuroamines in the treatment of depressive disorders. J Am Osteopath.Assoc 1984;84(1 Suppl):119-123. View abstract.

Mann, J., Peselow, E. D., Snyderman, S., and Gershon, S. D-phenylalanine in endogenous depression. Am.J.Psychiatry 1980;137(12):1611-1612. View abstract.

Rucklidge, J. J., Johnstone, J., and Kaplan, B. J. Nutrient supplementation approaches in the treatment of ADHD. Expert.Rev.Neurother. 2009;9(4):461-476. View abstract.

Sabelli, H. C., Fawcett, J., Gusovsky, F., Javaid, J. I., Wynn, P., Edwards, J., Jeffriess, H., and Kravitz, H. Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements. J Clin Psychiatry 1986;47(2):66-70. View abstract.

ten Hoedt, A. E., de Sonneville, L. M., Francois, B., ter Horst, N. M., Janssen, M. C., Rubio-Gozalbo, M. E., Wijburg, F. A., Hollak, C. E., and Bosch, A. M. High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial. J Inherit.Metab Dis. 2011;34(1):165-171. View abstract.

Wade, D. T., Young, C. A., Chaudhuri, K. R., and Davidson, D. L. A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis. J Neurol.Neurosurg.Psychiatry 2002;73(3):246-249. View abstract.

Amin A, Frampton J, Liu Z, et al. Differential effects of L- and D-phenylalanine on pancreatic and gastrointestinal hormone release in humans: A randomized crossover study. Diabetes Obes Metab. 2021 Jan;23(1):147-157. View abstract.

Antoniou C, Schulpis H, Michas T, et al. Vitiligo therapy with oral and topical phenylalanine with UVA exposure. Int J Dermatol 1989;28:545-7. View abstract.

Baker GB, Bornstein RA, Rouget AC, et al. Phenylethylaminergic mechanisms in attention-deficit disorder. Biol Psychiatry 1991;29:15-22.. View abstract.

Baruzzi A, Contin M, Riva R, et al. Influence of meal ingestion time on pharmacokinetics of orally administered levodopa in parkinsonian patients. Clin Neuropharmacol 1987;10:527-37. View abstract.

Beckmann H, Athen D, Olteanu M, Zimmer R. DL-phenylalanine versus imipramine: a double-blind controlled study. Arch Psychiatr Nervenkr 1979;227:49-58. View abstract.

Birkmayer W, Riederer P, Linauer W, Knoll J. L-deprenyl plus L-phenylalanine in the treatment of depression. J Neural Transm 1984;59:81-7. View abstract.

Bornstein RA, Baker GB, Carroll A, et al. Plasma amino acids in attention deficit disorder. Psychiatry Res 1990;33:301-6.. View abstract.

Cederbaum S. Phenylketonuria: an update. Curr Opin Pediatr 2002;14:702-6. View abstract.

Cejudo-Ferragud, E., Nacher, A., Polache, A., Cercos-Fortea, T., Merino, M., and Casabo, V. G. Evidence of competitive inhibition for the intestinal absorption of baclofen by phenylalanine. Int J of Pharm (Amsterdam) 1996;132:63-69.

Cormane RH, Siddiqui AH, Westerhof W, Schutgens RB. Phenylalanine and UVA light for the treatment of vitiligo. Arch Dermatol Res 1985;277:126-30. View abstract.

Cotzias GC, Van Woert MH, Schiffer LM. Aromatic amino acids and modification of parkinsonism. N Engl J Med 1967;276:374-9.

Eriksson T, Granerus AK, Linde A, et al. "On-off" phenomenon in Parkinson's disease: relationship between dopa and other large neutral amino acids in plasma. Neurology 1988;38:1245-8. View abstract.

Fitzgerald PCE, Manoliu B, Herbillon B, Steinert RE, Horowitz M, Feinle-Bisset C. Effects of L-phenylalanine on energy intake and glycaemia-impacts on appetite perceptions, gastrointestinal hormones and gastric emptying in healthy males. Nutrients. 2020 Jun 16;12(6):1788. View abstract.

Zhao G. [Inherited metabolic aberration of phenylalanine in the family members of patients with essential hypertension and stroke]. Chung Hua I Hsueh Tsa Chih (Taipei) 1991;71:28, 388-90. View abstract.

Bunions: Causes, Symptoms, and Treatments

Treating Psoriasis With Biologics: What to Know

Which Germs Might Lurk in Your Laundry?

Scalp Care: How to Soothe Irritation

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2024 by Therapeutic Research Center, LLC. All Rights Reserved.

PHENYLALANINE - Uses, Side Effects, and More